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The incidence of obesity is rising worldwide. Obesity is a risk factor for developing osteoarthritis in the knee.
Obesity and knee osteoarthritis are independently disabling conditions and in combination pose difficult
therapeutic challenges. This review will discuss obesity, osteoarthritis, and the problems associated with knee
osteoarthritis in an obese population. Treatment options including surgery and its success will be discussed.
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Obesity
Obesity is defined by the World Health Organisation
(WHO) as a body mass index (BMI) of greater than
30 kg/m2 that may impair a person’s health [1]. A BMI
between 25 kg/m2 and 30 kg/m2 is defined overweight.
It is important to note the WHO includes in its defin-
ition that this excess weight is caused by adipose tissue.
Athletic muscular individuals may possess a BMI greater
than 30 kg/m2 but would not be defined as obese. In
England, the National Institute for Clinical Excellence
(NICE) recommends the use of waist circumference
(greater than 102 cm in males and 88 cm in females) in
conjunction with BMI to define obesity [2].
The cause of obesity has been a subject for debate for
over a century and remains controversial [3]. Some con-
tend that obesity is caused by overeating alone, and a
net positive calorific intake leads to weight gain [4]. An
alternative hypothesis is that the type of calorific intake
is important and that the increase in refined sugars as a
proportion of our diet is responsible for the rise in obes-
ity [5]. Others argue that it is not merely the individual’s
dietary intake, but host factors such as abnormal bio-
chemical processing, or hormonal factors contribute [3].
Research on how diet affects body weight is difficult to
control and therefore much of the evidence is retro-
spective [6]. Although there is a need for well controlled
prospective studies to guide future management of* Correspondence: saifsalih@hotmail.com
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article, unless otherwise stated.obesity and public health policy there is without doubt
at present a significant disease burden as a direct result
of obesity [3].
Epidemiology
The WHO estimates that that the prevalence of obesity
has more than doubled since 1980, with more 10% of
the world’s population being defined as obese [1]. In
England up to a quarter of the population are obese [7],
with a slightly higher prevalence in women compared to
men [7]. This is not unique to the population of England.
In 18 out 27 European Union member states over 50% of
adults are overweight or obese. Similarly one third of
adults in the United States, and China are obese.
Health effects
Overweight and obesity are the fifth leading risk for
global deaths and account for an estimated 44% of
the diabetes burden, 23% of the ischaemic heart dis-
ease burden and between 7% and 41% of cancer bur-
dens [1]. There is a clear link between Osteoarthritis
(OA) and obesity, which will be discussed in more
detail within this review.
Review
Osteoarthritis
OA may be defined as a condition characterised by pro-
gressive loss of articular cartilage within a joint resulting
in pain [8]. It had previously been classed as a non-
inflammatory joint degeneration but there is increasing
evidence that the Greek etymology (osteo- bone, arthr-tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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the pathophysiology [9].
OA may be classified as primary or secondary [10].
Primary OA appears to have a genetic basis but no other
underlying pre-determinants. Secondary OA may de-
velop as a consequence of multiple causes (see Table 1).
There is a greater prevalence of OA between siblings
and especially identical twins [11]. Frizzle related protein
3 and Asporin have been identified from large genetic
studies as potentially important genes contributing to
OA [12].
OA is frequently described to patients as ‘wear and
tear’ that occurs with age; however, there are subtle dif-
ferences between the changes in articular cartilage that
occur with age and those seen in OA [9]. The hyaline
cartilage that lines synovial joints consists of chondro-
cytes and an extracellular matrix [13]. A normal extra-
cellular matrix is 75% water held by long proteoglycan
chains. With age these chains shorten, the water con-
tent, and the number of chondrocytes decrease. In OA
there is an initial increase in water content and chondro-
cyte number and it is postulated that this is a chondro-
cyte healing response to abnormal stresses [14]. With
progressive disease, chondrocyte numbers and proteo-
glycan content fall, as does water content. This results in
further damage to the articular cartilage and the release
of chondral debris and inflammatory mediators. This
triggers the innate immune system and starts a chronic
inflammatory cycle that further damages the joint [9].
The inflammatory mediators present in osteoarthritic
joints are similar to those found in rheumatoid joints
but present at lower concentrations.
Epidemiology
OA affects roughly 8 million people in the United
Kingdom and approximately 27 million people in the
United States [15]. The prevalence of OA increases
with age. The presence of radiological changes of OA
in many joints also increases with age. The reporting of
pain increases with increasing severity of radiographic
changes [16] but this does not mean radiographic changes
equate to pain. In one study half of men and a fifth of
women with severe radiographic changes in their hip orTable 1 Causes of secondary OA
Trauma
Infection
Deformity Secondary to developmental hip dysplasia or
Perthes’ disease.
Avascular necrosis
Other medical causes Renal disease, Sickle cell disease, Haemophilia,
Wilsons, Haemochromatosis, Endocrine
Skeletal dysplasiaknee did not report pain [17]. The presence of osteophytes
on a skyline view of the knee appears most predictive of
knee symptoms.
Knee OA
The knee joint is commonly affected by OA. The preva-
lence of knee OA is rising and this may be, at least in
part, due to the rising prevalence of obesity and an age-
ing population [18]. The Dutch cohort from Zoetemeer
showed increasing radiographic knee OA with age with
over half of women and a quarter of men having evidence
of disease [19]. There was no significant difference be-
tween the left and right knee. Data from the Framingham
cohort has shown self-reported knee pain has tripled in
men and doubled in women over thirty years [18]. This
disease burden appears to be increasing worldwide. The
prevalence of knee pain and OA in the Indian subcontin-
ent is approximately 35% [20]. The prevalence of knee
pain in the same ethnic group living in England is much
greater but the rate of OA within this group is very simi-
lar. The increase in knee pain may be attributable to an
unexplained increase in rheumatoid arthritis [21].
OA and obesity
Obesity is a recognised risk factor for developing knee
OA [22]. Several large studies have directly correlated
obesity with the knee OA [22–25]. A meta-analysis of
these demonstrated that there is an almost threefold
increase in the risk of developing OA within an obese
or overweight population [25]. This analysis also dem-
onstrated that the risk of developing OA increased in
proportion with increasing weight. Of all the studies
meeting the inclusion criteria in this meta-analysis
only one did not show a statistically significant in-
crease in prevalence of OA with increasing BMI [24].
However, this study did show a three-fold increase in
the relative risk of developing knee pain over a three-
year period with obesity.
In identical twins the risk of developing radiographic
changes at the patella-femoral and tibio-femoral joints in-
creases with weight [23]. For every kilogram of extra
weight there is a 9-13% increased risk of developing symp-
tomatic OA. On average twins with radiographic signs of
tibio-femoral OA were 2.93 kg heavier and those with
patella-femoral disease were 3.50 kg heavier. The patella-
femoral joint appears to be particularly susceptible to
radiographic changes with increased cartilage loss with in-
creasing BMI even in asymptomatic women [26].
The mechanical theory for the increased prevalence of
OA in obesity proposes that the extra force across a
joint from increased body mass is the cause, however
this theory is unlikely to explain the increased preva-
lence of OA found in the hands of those with a raised
BMI [23]. Obesity is part of the diagnostic criteria for
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grade pro-inflammatory state [27]. This may provide a
biochemical explanation for the link between obesity
and OA [14]. Adipokines have been implicated as a po-
tential mediator of this effect. Adipokines are cytokines
that are predominantly released by adipose tissue into
the bloodstream [28]. Adiponectin is one of these adipo-
kines and its concentration is increased in patients with
OA, especially in obese females. However this same
study demonstrated there was only a weak correlation
between increased adiponectin and synovial inflamma-
tion and there was no direct correlation with articular
cartilage damage [29]. In another study increased adipo-
kines and adipokine receptors were associated with
cartilage damage, but not with obesity [30]. A large
study of over 1000 patients suggested that elevated
adiponectin and resistin (another adipokine) were only
weakly associated with OA and obesity but there was a
stronger positive correlation between OA and obesity and
leptin [31].
Magnetic resonance imaging studies of overweight pa-
tients are interesting. One study correlated increased
body weight with a greater presence of bone marrow le-
sions and cartilage defects but not with knee pain [32].
Further studies demonstrated that, regardless of pre-
existing radiographic severity, weight loss improved knee
pain symptoms [33], but does not improve the MRI ap-
pearance of cartilage defects or bone marrow lesions
[34]. These findings highlight that knee pain is subject-
ive, as is the perception of disability secondary to knee
pain [35]. Data from the Chingford cohort demonstrates
that a raised BMI is an independent risk factor for self-
reported knee pain regardless of radiographic severity of
disease [36].
Despite evidence that weight loss can improve knee pain
symptoms many patients claim that their knee pain pre-
cludes losing weight [37]. Patients with a BMI >35 kg/m2
are recognised to undergo surgery for OA an earlier age
[38]. The reasons for this are multifactorial but in part
may be that obese patients with OA are more likely to
seek a surgical solution than those of a normal BMI.
Arthroplasty in obese individuals
Associated with an ageing population and rising rates of
obesity, the number of total knee arthroplasties (TKA)
are rising and now surpass total hip arthroplasty (THA)
[39]. It is anticipated that the number of TKA being per-
formed in the overweight and obese is likely to continue
to rise [40]. The success, failure and outcome of TKA
are potentially altered in overweight or obese patients
[37,38,41–43].
TKA in obese individuals is technically more challen-
ging, takes longer to perform and larger exposures are
required to provide surgical access. The risk of intra-operative surgical complications is higher in patients
with an elevated BMI. These include higher blood trans-
fusion requirements as a result of operative blood loss
[44], difficulty in identifying anatomy leading to iatro-
genic damage (in particular medial collateral ligament
avulsion [45]), or mal-alignment of the prosthesis [46].
The risk of post-operative complications in obese pa-
tients is also reportedly raised with rates as high as 32%
[44,45,47]. This rate is primarily caused by superficial and
deep surgical site infections and post-operative venous-
thromboembolic (VTE) complications [48]. For THA and
TKA the risk of VTE disease increases by 1.5 for every
5 kg/m2 of increased BMI [49]. A meta-analysis of surgical
complications showed deep infection requiring surgical
debridement occurs more frequently in obese individuals
with an odds ratio of 2.38 and the risk of infection is 1.9
times greater [41]. However with the data available from
the included studies, the risk of revision for infection was
not significantly higher in obese individuals. Interestingly
this same meta-analysis suggests that there is no increased
risk of intra-operative injury, or post-operative VTE com-
plication as a result of obesity. In contrast to other studies
a further confounding analysis of Italian registry data of
nearly 9000 patients suggested no significant increase in
intra-operative complication, or post-operative infection,
VTE disease or death in the obese group [50]. In conclu-
sion the evidence suggests a higher risk of intra and post-
operative complications of TKA for OA in obese patients
but there remains some controversy in this area.
Implant survival
Data from THR wear studies suggests that implant sur-
vival is reduced in obese patients [51]. In light of this
evidence it has been hypothesised that TKA would also
fail more quickly in obese individuals because the in-
creased load across the implant would increase wear. It
is important to note that the mechanism of wear occur-
ring in a TKA is different to that that is generated at a
THA.
There is evidence that at five years obese patients had
no increased revision rate compared with patients with a
normal BMI. The authors of this study suggested that
the follow-up period was too short to detect any differ-
ence or that obese patients were less active, offsetting
the effect of increased loads across the joint [43]. A fur-
ther study with a longer follow-up period demonstrated
that at seven years the implant failure rate, as defined ei-
ther clinically (Knee Society Score- KSS) or radiograph-
ically, is significantly higher in the obese population [52].
Meta-analysis shows that the overall revision rate is 1.79
times higher in an obese group of patients compared
with patients with a normal BMI after five years follow
up [41]. This, however, is ‘all cause’ revision and includes
both revision for infection and aseptic failures. In one
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is likely that higher implant failure and revision rates
in obese patients are likely to be attributable to a
higher rate of wear, aseptic loosening and infection [41].
Vazquez-Vela’s et al. [53] showed that at ten years
only a third of TKA in obese men aged under 60 years
survived. In comparison the highest survival rate was
99.42% in non-obese women aged over 60 years.
Following TKR obese patients do report an improve-
ment in symptoms based on the KSS [43,54,55]. Many
groups report that post-operative KSS is significantly
lower in an obese population, however, the level of im-
provement is similar to the non-obese group [45,54,55].
Several groups report that the obese are less happy with
their TKA [37,42] but these patients may appear to per-
form worse because of other medical co-morbidities
[37]. Pre-operative obesity attributed to the inability to
exercise because of knee pain does not appear to resolve
with surgery. Dowsey et al. [37] reported that 21% of an
obese group of patients gained weight and only 14% lost
weight after TKA.
The morbidly obese represent a different subclass
within the overweight and obese population. These are
defined as patients with a BMI >35 kg/m2 [1]. There is
evidence that this group responds differently to the
group of patients who are overweight or obese (but not
considered morbidly obese) to TKA.
The surgical challenges are more extreme in the mor-
bidly obese, they are slower to recover post-operatively
[54] and have a greater rate of complications [48,55,56].
With a BMI >40 kg/m2 patients have lower self-reported
outcome scores, increased radiographic evidence of
aseptic loosening and higher revision rates [48]. Patient
reported outcome is worse in the morbidly obese com-
pared to the non-morbidly obese but the morbidly obese
show bigger improvements in function when compared
to their pre-operative state [57] and by three years the
morbidly obese appear to do as well as non-obese coun-
terparts [54].
Interestingly survival at 80 months appears better in
the morbidly obese compared with non-morbidly obese
patients, but both are worse than the non-obese patients
[52]. The explanation for this may be because the mor-
bidly obese are less active than the non-morbidly obese.
A further confounding effect is suggested by some stud-
ies, which point to data skewing of the whole obese
population by the subgroup of the morbidly obese. Some
authors claim that if the non-morbidly obese are ana-
lysed independently of the morbidly obese population
they behave in a similar manner to a non-obese popula-
tion in terms of outcome and implant survival [55]. In
the authors’ opinion weight loss in the morbidly obese
prior to knee surgery should be advised to reduce com-
plication rate and improve long-term outcome. Bariatricsurgery may be considered as a method of rapid weight
loss prior to TKA and there is evidence that this im-
proves the radiographic evidence of OA and symptoms
[58]. There is however only limited evidence that this
improves post-operative complication rates for those
who undergo TKA and are morbidly obese prior to knee
surgery [59].
Conclusions
Obesity is an increasing worldwide problem and the de-
mand for TKA in this patient group is likely to continue
to increase.
Obese patients are at greater risk of peri-operative
complications and the overall evidence suggests they are
at increased risk of premature joint failure and revision.
The overall outcome of TKA in obese patients is worse
than the non-obese group; however, the absolute im-
provements are similar in both groups. Obese patients
should not expect TKA to enable them to lose weight.
There is data to support the use of TKA in an obese
population and that it can provide long term benefit,
but the patients must be made aware of the increased
risk of peri-operative complications, the potential for
re-operation and advantages of weight loss prior to
surgical treatment.
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